This article was first published in Kluwer Blog [August, 2024]. Background In June 2024, we reported that in an application for...

Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...

This article was first published in EPLAW blog [August, 2024]. Patents Court finds Janssen Biotech’s patent, for the antibody ustekinumab...

Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...

This article was first published in Kluwer Patent Blog [July 2024]. In his Abbott v Dexcom ([2024] EWHC 1664 (Pat)) judgment, published...

This article was first published in Kluwer Patent Blog [June, 2024]. Introduction On 19 June 2024, The Hague Local Division handed down a...

Introduction The NHS’ Health Research Authority (HRA) recently published its draft template Investigator Initiated Study Agreement (IIS...

It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...

Bristows was delighted to sponsor and attend this year’s EU Pharmaceutical Law Forum, which was held in Brussels at the Steigenberger...

We enjoyed an interesting day hearing about tech and healthcare at the recent WIRED Health conference. The conference brings together...

A brief analysis of the interaction between the proposed AI Act and the MDR The AI Act continues to contain a concerning flaw as regards...

On 9 January 2024, the MHRA published a new Regulatory Roadmap, which sets out the expected timeline and key milestones on the way to the...